Stocks and Investing
Stocks and Investing
Fri, November 10, 2017
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Thu, November 9, 2017
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Andrew Schenker Maintained (THC) at Hold with Decreased Target to $14 on, Nov 9th, 2017
Andrew Schenker of Morgan Stanley, Maintained "Tenet Healthcare Corporation" (THC) at Hold with Decreased Target from $15 to $14 on, Nov 9th, 2017.
Andrew has made no other calls on THC in the last 4 months.
There are 4 other peers that have a rating on THC. Out of the 4 peers that are also analyzing THC, 1 agrees with Andrew's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Scott Fidel of "Credit Suisse" Initiated at Hold and Held Target at $15 on, Thursday, November 2nd, 2017
These are the ratings of the 3 analyists that currently disagree with Andrew
- Brian Tanquilut of "Jefferies" Maintained at Strong Buy with Decreased Target to $20 on, Monday, October 30th, 2017
- Ana Gupte of "Leerink Swann" Maintained at Buy with Increased Target to $30 on, Monday, August 21st, 2017
- Christopher Rigg of "Deutsche Bank" Maintained at Strong Buy with Decreased Target to $24 on, Thursday, August 10th, 2017